This multicomponent toolkit has been developed to facilitate the commercialization of Lamictal and to assist you in meeting the challenge to successfully position Lamictal in the treatment of bipolar disorder.

The toolkit contains a comprehensive collection of key data on Lamictal and its competitors in bipolar disorder. The information is sourced from peer-reviewed literature, recent conferences, international and national guidelines, and feedback from local markets. For each of the products reviewed, the following components are included:

Positioning, strengths, and weaknesses
These sections can be used as a basis for developing local market strategies.

Key claims and counter claims
Each product section contains key claims developed through an extensive search of all peer-reviewed literature and posters and abstracts from recent conferences. This unique feature, providing the key claims for Lamictal and competitor counter claims, allows identification of the areas where Lamictal has an advantage over its competitors.

Country information
In this section, key information including regulatory status, launch date, registered indications, and promotional material (where available) is included.

Additional features
The data on this CD-ROM is fully referenced. External hyperlinks give you direct access to abstracts and/or papers that are publicly accessible on the Internet.

Search function
The search function allows you to conduct a free-text search.

This CD-ROM will be updated regularly to include the latest literature, marketing strategies, and feedback from local markets. We trust that this toolkit will be a valuable source of information for you.

Version 1.1 May 2004